Get started
Author

Brenda E. Moore

Observed name: Brenda Moore
Institution: Mayo Clinic
Observed institution: Mayo Clinic
OpenAlex ID: A5010253230
Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis
2001 · Jeng-Hsien Yen, Brenda E. Moore, et al. · The Journal of Experimental Medicine · 335
PDF
Preemptive Pharmacogenomic Testing for Precision Medicine
2016 · Yuan Ji, Jennifer M. Skierka, et al. · Journal of Molecular Diagnostics · 198
PDF
Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study
2022 · Liewei Wang, Steven E. Scherer, et al. · Genetics in Medicine · 74
PDF
Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism
2007 · Linnea M. Baudhuin, W. Edward Highsmith, et al. · Clinical Biochemistry · 29
Genetic variants related to successful migraine prophylaxis with verapamil
2021 · Fred Michael Cutrer, Ann M. Moyer, et al. · Molecular Genetics & Genomic Medicine · 21
PDF
Mitigating Exertional Heat Illness in Military Personnel: The Science Behind a Rice-Based Electrolyte and Rehydration Drink
2016 · Brenda Moore, Reginald O'Hara · Journal of Special Operations Medicine · 1
Comparison of Oral Rehydration Drinks and their Effects on Physical Performance in United States Military Personnel
2019 · Reginald O’Hara, Brenda E. Moore
Works count: 7
Citation count: 658
H-index: 5
I10-index: 5
Year
Topic
Type